首页/数据集/Dataset from Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)

Dataset from Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)

NIAID Data Ecosystem2026-05-02 收录

多发性硬化症治疗

药物联合疗法评估

数据链接：

https://doi.org/10.25934/00002836 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to determine if natalizumab in combination with Glatiramer Acetate (GA) is safe and effective in delaying progression of individuals diagnosed with relapsing-remitting Multiple Sclerosis (MS).

应用场景：

创建时间：

2024-11-26

多发性硬化症治疗

灵芝药理

Supporting data for thesis “Therapeutic Effects of Ganoderma and Its Active Ingredients on Microglial Activation and Polarization in Multiple Sclerosis Treatment”Multiple Sclerosis (MS), a neurodegene

DataCite Commons2024-08-09 更新90

Characteristics of the study cohort at the index date overall and by the initial DMT prescribed.

多发性硬化症治疗

疾病修饰疗法疗效评估

GA = glatiramer acetate; IFN-β = interferon-beta; EDSS = Expanded Disability Status Scale; y = years.aIFN-β-1a s.c. (n = 411), IFN-β-1b (n = 120), IFN-β-1a i.m. (n = 34).bMissing in 6 patients; of 8 p

Figshare2015-12-03 更新50

Table S1 - Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

多发性硬化症治疗

药物疗效比较

Assignation to treatment dosage by treating centres. The table shows number of patients assigned to either Rebif dosage at each of the participating centres. Odds relative to the reference centre (IT-

Figshare2015-12-02 更新30

Clinical and demographic details of patients and healthy controls.

多发性硬化症治疗

临床数据

†Copaxone®;‡Avonex® n = 5, Betaferon® n = 5, Rebif® 22 n = 4, Rebif® 44 n = 8; SD: standard deviation.

Figshare2015-12-02 更新60

Dataset from Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years

多发性硬化症治疗

药物动力学评估

The primary objective of this study is to evaluate the effect of BG00012 (dimethyl fumarate) on brain magnetic resonance imaging (MRI) lesions in pediatric participants with relapsing-remitting multip

NIAID Data Ecosystem40

Dataset from Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)

资源简介：

相关数据集